Navigation Links
Tecnalia develops environment-friendly and health-friendly pest control products
Date:10/20/2010

Tecnalia, through its Construction Unit, is participating in and coordinating a European FP7 research project for SMEs, called Bimosyn. The aim is to develop pest control products with lower concentrations of biocides and, thereby, be more environmentally friendly and less damaging for human health. The two years lasting project will be carried out jointly with the Swedish University of Agricultural Sciences (SLU) and five SME companies: Berkem (France), Linotech (Sweden), Rutlandbio (the United Kingdom), Quadrifolio (Portugal) and Dts-Oabe (Spain). These companies will be responsible for marketing the new products developed.

The scientific development of the project involves research into the degree of synergy between bioactive antioxidant substances (natural phenolic compounds, such as anthocyanins) and conventional insecticides and fungicides. The aim is to use natural, vegetable-origin extracts with the potential for being employed as biocide adjuvants for the chemical sector. In this way, pest control products which will have the same efficacy as conventional ones can be obtained and, at the same time, will not be prejudicial for the environment or to human health. The new pesticides will act to combat plague of flies, cockroaches, termites and wood-rotting fungi.

The project involves the study of the synergy between bioactive antioxidant molecules and synthetic biocides within the new European Biocide Products Directive 98/8/CE (BPD). The idea of this is to develop new pesticide product formulations which can be clearly differentiated in the market with respect to conventional, more contaminant pesticides. Other objectives of the project are to attain products which are competitive from a business and commercial perspective, as well as promoting the use of these pesticides in the construction sector.

Future challenges

Notable amongst the tasks to be undertaken is that the researchers will gather all the basic antioxidant materials, extracts of medicinal plants and biocides necessary for drawing up the project, with the aim of studying the synergic effects amongst them. The next step is drawing up various formulae with antioxidant or medicinal plant extracts mixed with biocides selected in the previous stage.

Then the efficacy of the different formulae will be evaluated with trials based on a number of European and international norms in matters of pest control. Finally, data on cost analysis will be obtained in order to help in reducing the price of the final product.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. UCLA develops combat casualty care educational program for US armed forces
2. Team led by LA BioMed scientist develops novel approach to study neurological disorders
3. Brain Develops Differently in Fragile X Syndrome
4. Olympus develops worlds fastest, most compatible endoscope reprocessor
5. Military develops multi-purpose green decontaminants for terrorist attack sites
6. How, When Child Develops Autism May Determine Outcomes
7. UMass Memorial health care develops fully integrated EMR
8. UD team develops new method for producing proteins critical to medical research
9. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
10. Personal Best Develops Workplace Weight Loss Program
11. Even Well-Controlled Diabetes May Present Post-Surgery Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... ... May 26, 2016- In search of the K. Warriors, Shaolin Institute is presenting ... on June 4, 2016 at Ashbury Hotel and Suites 600 West Interstate 65 Service ... Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is the 28th US ...
(Date:5/27/2016)... ... , ... Two director-level employees of Horizon Blue Cross Blue Shield of New ... honorees. The award recognizes businesswomen who excel in their fields and who have ... MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa Ponton, ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational ... by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also ... advocates, associations and industry leaders such as Bioness. , As patients feel ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard ... Allison Outerbridge is this year’s Life University winner of a $2,500 ... university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, ... respirators, according to court documents and SEC filings. A jury has returned ... v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
(Date:5/25/2016)... NEW YORK , May 25, 2016  According ... devices reached $381 billion in 2015.  Though these ... still plenty of opportunity for success for companies ... end, in search of new growth prospects medical ... revenue on research and development (R&D) than do ...
Breaking Medicine Technology: